Core Laboratories Inc (CLB) has a current Price-to-Book (P/B) ratio of 2.88. Compared to its 3-year average P/B ratio of 3.62, the current P/B ratio is approximately -20.58% higher. Relative to its 5-year average P/B ratio of 5.51, the current P/B ratio is about -47.73% higher. Core Laboratories Inc (CLB) has a Forward Free Cash Flow (FCF) yield of approximately 4.36%. Compared to its 3-year average FCF yield of 3.67%, the current FCF yield is approximately 18.77% lower. Relative to its 5-year average FCF yield of 2.72%, the current FCF yield is about 60.23% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CLB competitors is 1.70, providing a benchmark for relative valuation. Core Laboratories Inc Corp (CLB.N) exhibits a P/S ratio of 1.52, which is -10.76% above the industry average. Given its robust revenue growth of 6.98%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CLB increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CLB in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CLB currently overvalued or undervalued?

What is Core Laboratories Inc (CLB) fair value?

CLB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Core Laboratories Inc (CLB) is between 15.29 to 27.09 according to relative valuation method.

How does CLB's valuation metrics compare to the industry average?

The average P/S ratio for CLB's competitors is 1.70, providing a benchmark for relative valuation. Core Laboratories Inc Corp (CLB) exhibits a P/S ratio of 1.52, which is -10.76% above the industry average. Given its robust revenue growth of 6.98%, this premium appears unsustainable.

What is the current P/B ratio for Core Laboratories Inc (CLB) as of Mar 03 2026?

As of Mar 03 2026, Core Laboratories Inc (CLB) has a P/B ratio of 2.88. This indicates that the market values CLB at 2.88 times its book value.

What is the current FCF Yield for Core Laboratories Inc (CLB) as of Mar 03 2026?

As of Mar 03 2026, Core Laboratories Inc (CLB) has a FCF Yield of 4.36%. This means that for every dollar of Core Laboratories Inc's market capitalization, the company generates 4.36 cents in free cash flow.

What is the current Forward P/E ratio for Core Laboratories Inc (CLB) as of Mar 03 2026?

As of Mar 03 2026, Core Laboratories Inc (CLB) has a Forward P/E ratio of 22.91. This means the market is willing to pay $22.91 for every dollar of Core Laboratories Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Core Laboratories Inc (CLB) as of Mar 03 2026?

As of Mar 03 2026, Core Laboratories Inc (CLB) has a Forward P/S ratio of 1.52. This means the market is valuing CLB at $1.52 for every dollar of expected revenue over the next 12 months.

CLB Valuation